4.7 Article

DNA damage-specific deubiquitination regulates Rad18 functions to suppress mutagenesis

期刊

JOURNAL OF CELL BIOLOGY
卷 206, 期 2, 页码 183-197

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201311063

关键词

-

资金

  1. National Defense Science and Engineering Graduate Fellowship
  2. National Cancer Institute training grant [PHS CA09302]
  3. Department of Defense (Breast Cancer Research Program) Predoctoral Fellowship [W81XNA/H-09-1-0026]
  4. National Institutes of Health training grant [R90 DK071499]
  5. Ministry of Economy and Competitiveness grants [SAF2010-22357, CONSOLIDERIngenio 2010 CDS2007-0015]
  6. National Institutes of Health grant [ES016486]

向作者/读者索取更多资源

D eoxyribonucleic acid (DNA) lesions encountered during replication are often bypassed using DNA damage tolerance (DDT) pathways to avoid prolonged fork stalling and allow for completion of DNA replication. Rad18 is a central E3 ubiquitin ligase in DDT, which exists in a monoubiquitinated (Rad18Ub) and nonubiquitinated form in human cells. We find that Radl 8 is deubiquitinated when cells are treated with methyl methanesulfonate or hydrogen peroxide. The ubiquitinated form of Radl 8 does not interact with SNF2 histone linker plant homeodomain RING helicase (SHPRH) or helicase-like transcription factor, two downstream E3 ligases needed to carry out error-free bypass of DNA lesions. Instead, it interacts preferentially with the zinc finger domain of another, nonubiquitinated Radl 8 and may inhibit Rad18 function in trans. Ubiquitination also prevents Rad18 from localizing to sites of DNA damage, inducing proliferating cell nuclear antigen monoubiquitination, and suppressing mutagenesis. These data reveal a new role for monoubiquitination in controlling Radl 8 function and suggest that damage-specific deubiquitination promotes a switch from Rad18Ub Rad18 complexes to the Rad] 8-SHPRH complexes necessary for error-free lesion bypass in cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据